In the Courts
TERM 2
May 2026 · 45 days ago
🏥 Healthcare
The Trump administration issued a Centers for Medicare and Medicaid Services (CMS) rule creating exemptions to Medicaid work requirements for individuals deemed 'medically frail.' A coalition of 25 states and DC sued, arguing the rule violates congressional protections and inadequately defines medical frailty. The exemption affects hundreds of thousands of vulnerable Medicaid beneficiaries who risk losing coverage if unable to meet work hour requirements.
In the Courts
TERM 2
May 2026 · 49 days ago
🏥 Healthcare
The Trump administration's termination of Temporary Protected Status (TPS) for multiple nationalities removes legal work authorization from thousands of healthcare workers, including nurses and nursing assistants, destabilizing hospital staffing and patient care. The policy forces documented workers into undocumented status or deportation, directly harming vulnerable patients like those with life-threatening illnesses who depend on continuity of care. The action escalates immigration enforcement targeting essential workers during a documented healthcare labor shortage.
In the Courts
TERM 1
September 13, 2020 · 2,128 days ago
🏥 Healthcare
President Trump signed Executive Order 13948 on September 13, 2020, directing the Department of Health and Human Services to allow Medicare to pay no more for drugs than the lowest price paid in other developed countries. The order applied to a subset of Medicare Part B drugs. As of 2021, the rule was blocked by federal courts before implementation, preventing direct Medicare price changes for most drugs covered under the order.
In the Courts
TERM 1
July 24, 2020 · 2,179 days ago
🏥 Healthcare
Executive Order 13939 was signed on July 24, 2020, directing the Department of Health and Human Services to issue a safe harbor rule removing anti-kickback protections for rebates in drug pricing negotiations. The order aimed to increase price transparency by allowing pharmaceutical manufacturers, pharmacy benefit managers, and health plans to negotiate rebates directly. The confirmed effect was that HHS issued a proposed rule in January 2021 to modify anti-kickback statute safe harbors, though implementation faced legal challenges and the rule's real-world impact on patient drug prices remained subject to ongoing litigation.